BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 22381246)

  • 1. Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome.
    Mester JL; Zhou M; Prescott N; Eng C
    Urology; 2012 May; 79(5):1187.e1-7. PubMed ID: 22381246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Neoplasia Occurring in Patients With PTEN Hamartoma Tumor Syndrome : Clinicopathologic Study of 12 Renal Cell Carcinomas From 9 Patients and Association With Intrarenal "Lipomas".
    Kozman D; Kao CS; Nguyen JK; Smith SC; Kehr EL; Tretiakova M; Przybycin CG; Williamson SR; Argani P; Eng C; Campbell SC; McKenney JK; Alaghehbandan R
    Am J Surg Pathol; 2023 Sep; 47(9):1001-1010. PubMed ID: 37357918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN Hamartoma Tumor Syndrome: A Case of Renal Cell Carcinoma in a Young Female.
    Ramkumar RR; Murthy PB; Nguyen JK; McKenney J; Eng C; Campbell SC
    Urology; 2021 Feb; 148():113-117. PubMed ID: 33227300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline PTEN mutation Cowden syndrome: an underappreciated form of hereditary kidney cancer.
    Shuch B; Ricketts CJ; Vocke CD; Komiya T; Middelton LA; Kauffman EC; Merino MJ; Metwalli AR; Dennis P; Linehan WM
    J Urol; 2013 Dec; 190(6):1990-8. PubMed ID: 23764071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma- results from a nation-wide study covering 50 years in Iceland.
    Runarsson TG; Bergmann A; Erlingsdottir G; Petursdottir V; Heitmann LA; Johannesson A; Asbjornsson V; Axelsson T; Hilmarsson R; Gudbjartsson T
    BMC Urol; 2024 May; 24(1):105. PubMed ID: 38741053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Analysis of Cancer Risk in Children and Adults With Germline PTEN Variants.
    Yehia L; Plitt G; Tushar AM; Joo J; Burke CA; Campbell SC; Heiden K; Jin J; Macaron C; Michener CM; Pederson HJ; Radhakrishnan K; Shin J; Tamburro J; Patil S; Eng C
    JAMA Netw Open; 2023 Apr; 6(4):e239705. PubMed ID: 37093598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifetime cancer risks in individuals with germline PTEN mutations.
    Tan MH; Mester JL; Ngeow J; Rybicki LA; Orloff MS; Eng C
    Clin Cancer Res; 2012 Jan; 18(2):400-7. PubMed ID: 22252256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline and somatic DNA methylation and epigenetic regulation of KILLIN in renal cell carcinoma.
    Bennett KL; Campbell R; Ganapathi S; Zhou M; Rini B; Ganapathi R; Neumann HP; Eng C
    Genes Chromosomes Cancer; 2011 Aug; 50(8):654-61. PubMed ID: 21584899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model.
    Mester JL; Tilot AK; Rybicki LA; Frazier TW; Eng C
    Eur J Hum Genet; 2011 Jul; 19(7):763-8. PubMed ID: 21343951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity.
    Laury AR; Bongiovanni M; Tille JC; Kozakewich H; Nosé V
    Thyroid; 2011 Feb; 21(2):135-44. PubMed ID: 21190448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural History of Thyroid Disease in Children with PTEN Hamartoma Tumor Syndrome.
    Smith JR; Liu E; Church AJ; Asch E; Cherella CE; Srivastava S; Kamihara J; Wassner AJ
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1121-e1130. PubMed ID: 33347563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colonic manifestations of PTEN hamartoma tumor syndrome: case series and systematic review.
    Stanich PP; Pilarski R; Rock J; Frankel WL; El-Dika S; Meyer MM
    World J Gastroenterol; 2014 Feb; 20(7):1833-8. PubMed ID: 24587660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome.
    Roldan-Romero JM; Santos M; Lanillos J; Caleiras E; Anguera G; Maroto P; García-Donas J; de Velasco G; Martinez-Montes ÁM; Calsina B; Monteagudo M; Letón R; Leandro-García LJ; Montero-Conde C; Cascón A; Robledo M; Rodriguez-Antona C
    Mod Pathol; 2020 Dec; 33(12):2580-2590. PubMed ID: 32616874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome.
    Hendricks LAJ; Hoogerbrugge N; Mensenkamp AR; Brunet J; Lleuger-Pujol R; Høberg-Vetti H; Tveit Haavind M; Innella G; Turchetti D; Aretz S; Spier I; Tischkowitz M; Jahn A; Links TP; Olderode-Berends MJW; Blatnik A; Leter EM; Evans DG; Woodward ER; Steinke-Lange V; Anastasiadou VC; Colas C; Villy MC; Benusiglio PR; Gerasimenko A; Barili V; Branchaud M; Houdayer C; Tesi B; Yazicioglu MO; van der Post RS; Schuurs-Hoeijmakers JHM; ; Vos JR
    J Natl Cancer Inst; 2023 Jan; 115(1):93-103. PubMed ID: 36171661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of CT, MRI imaging features of renal cell carcinoma with different histopathological types.
    Wang X; Kong W; Wang Y; Wang Y; Chen Y; Shi Z; Liu Y
    J BUON; 2021; 26(5):2053-2058. PubMed ID: 34761616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN hamartoma tumour syndrome: case report based on data from the Iranian hereditary colorectal cancer registry and literature review.
    Rahmatinejad Z; Goshayeshi L; Bergquist R; Goshayeshi L; Golabpour A; Hoseini B
    Diagn Pathol; 2023 Apr; 18(1):43. PubMed ID: 37016356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome.
    Bubien V; Bonnet F; Brouste V; Hoppe S; Barouk-Simonet E; David A; Edery P; Bottani A; Layet V; Caron O; Gilbert-Dussardier B; Delnatte C; Dugast C; Fricker JP; Bonneau D; Sevenet N; Longy M; Caux F;
    J Med Genet; 2013 Apr; 50(4):255-63. PubMed ID: 23335809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
    Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
    Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between the PTEN/MMAC1/TEP1 expression and cell proliferation and apoptosis in human renal cell carcinoma (RCC)].
    Li JY; Cao RF; Wang H; Xie QX; Wang GX; Xiong LS; Miao YR
    Ai Zheng; 2003 Jun; 22(6):607-11. PubMed ID: 12948410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain morphological analysis in PTEN hamartoma tumor syndrome.
    Shiohama T; Levman J; Vasung L; Takahashi E
    Am J Med Genet A; 2020 May; 182(5):1117-1129. PubMed ID: 32162846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.